lead position
Patents
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
November 6, 2025
Features list
-
Avoiding the double-filing of trademarks and designs and transferring .EU domain registrations are just two recommendations for IP owners in light of Brexit, as Beverley Potts, David Stone, Joachim Feldges, Keren Livneh and David Shen of Allen & Overy explain -
Following the highly-anticipated UK Supreme Court decision in Warner-Lambert v Generics on plausibility in November 2018, the High Court applied the new plausibility test for the first time in March, as Varuni Paranavitane of AA Thornton explains
-
Sarah Turner, Darren Meale and Adrian Smith of Simmons & Simmons consider what brand owners can do when faced with a bad faith trademark application and how to prepare for a potentially important CJEU decision
-
Charlie Winckworth and Andrew Linch of Cooley look at the controversial provisions of the newly-approved EU Copyright Directive and assess what’s next for the tech companies that will be most affected
-
The divisions caused by the EU Copyright Directive, which is awaiting implementation by member states, are likely to continue in court, as David Braid finds out
-
Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies
Local Insights
Sponsored by
Shiga International Patent Office
Masato Iida of Shiga International Patent Office says the decision by the Grand Panel of the Intellectual Property High Court provides a practical benchmark for calculating damages in cosmetic and medical patent infringement cases
Sponsored by
Berken IP
María Aurora García of Berken IP explains how Argentina’s evolving non-use cancellation system strengthens trademark integrity, streamlines registration, and promotes fairer market competition through efficient, partial, and administrative cancellation mechanisms
Sponsored by
Licks Attorneys
How UK extraterritorial decisions are undermining Brazilian judicial sovereignty and violating TRIPS
Senior patent attorneys at Licks Attorneys say recent UK court decisions on FRAND licensing conflict with Brazilian judicial sovereignty and the TRIPS framework governing the territorial independence of patents
Sponsored by
Gün and Partners
Selin Sinem Erciyas of Gün + Partners explores the growing alignment between Turkish courts and the Unified Patent Court in applying a strictly technical-functional standard for patent infringement by equivalence
Sponsored by
Liu, Shen & Associates
Wenjing Zhu of Liu, Shen & Associates explains how China’s administrative adjudication system is reshaping patent enforcement, offering faster, cost-effective, and technically expert resolutions for patentees, while preserving rights to pursue court remedies
Sponsored by
Wanhuida Intellectual Property
Minnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
Sponsored by
Inventa
Vítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
Sponsored by
Tilleke & Gibbins
Vietnam’s boom in AI-generated songs raises fundamental copyright questions, say Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
Sponsored by
Hanol IP & Law
Min Son of Hanol IP & Law explains why the ruling by South Korea’s Intellectual Property High Court marks a key development in online patent enforcement
Sponsored by
Becerril, Coca & Becerril
Carlos Hernández León of Becerril, Coca & Becerril outlines how Mexico’s shift from NAFTA-based patent term extensions to the new SPC regime affects patent holders , particularly in pharmaceuticals, and the strategic steps to secure additional protection